Open AccessPMON171 DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Pituitary Neuroendocrine Tumoral Cells
Author(s) -
Federica Mangili,
Emanuela Esposito,
Donatella Treppiedi,
Rosa Catalano,
Giusy Marra,
Genesio D Muro,
Marco Locatelli,
Andrea Lania,
Maura Arosio,
Giovanna Mantovani,
Erika Peverelli
Publication year - 2022
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/jendso/bvac150.1141
Subject(s) - everolimus , pi3k/akt/mtor pathway , protein kinase b , cabergoline , phosphorylation , pharmacology , cancer research , neuroendocrine tumors , chemistry , medicine , endocrinology , signal transduction , prolactin , biochemistry , hormone
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom